NIH-funded research R01 grant

Investigating how genetic risk and inflammation affect brain health in older adults.

Official title: Brain Vulnerability in Delirium and Alzheimer’s Disease and Related Dementias: Intersection of Polygenic Risk and Inflammation

Funded at Beth Israel Deaconess Medical Center · NIH-10987037 · Data updated 2026-11-12

This study is looking at how certain genes linked to Alzheimer's and other dementias work with inflammation to affect brain health in older adults, especially after things like surgery or infections, to help identify those who might be at greater risk for memory problems.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startFebruary 1, 2023
Project endNovember 30, 2027
Funding year2025
Award (this year)$746,750
NIH project number5R01AG079864-03
Project IDNIH-10987037 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults, particularly those aged 65 and above, who may have a genetic predisposition to Alzheimer's Disease or related dementias.

Less likely to help

Patients under the age of 65 or those without a genetic risk for Alzheimer's Disease may not benefit from this research.

What this research studies

This research aims to understand how genetic factors related to Alzheimer's Disease and related dementias interact with inflammation to influence brain health in older adults. By examining the genetic predisposition of individuals, the study seeks to identify those who may be at higher risk for developing conditions like delirium and cognitive decline, especially after experiencing inflammatory events such as surgery or infections. The approach involves analyzing multiple genetic markers rather than focusing on single genes, allowing for a more comprehensive understanding of the risks involved. This research could lead to better identification of vulnerable individuals and inform preventive strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing cognitive decline and delirium in older adults.

How similar studies have gone: Previous research has shown promising results in understanding the links between genetic risk factors and cognitive decline, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Vasunilashorn, Sarinnapha — Beth Israel Deaconess Medical Center
  • Study coordinator: Vasunilashorn, Sarinnapha

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.